1. Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation
   Jennifer C. Brazil et al, 2021, Mucosal Immunol CrossRef
2. Structure and Function of Potential Glycosylation Sites of Dynactin-Associated Protein dynAP
   Xiaobo Yin et al, 2022, Mol Biotechnol CrossRef
3. Development of Urinary Diagnostic Biomarker for IgA Nephropathy by Lectin Microarray
   Yasuhiro Onishi et al, 2022, Am J Nephrol CrossRef
4. Nascent Glycoproteome Reveals That N-Linked Glycosylation Inhibitor-1 Suppresses Expression of Glycosylated Lysosome-Associated Membrane Protein-2
   Xinyi Cao et al, 2022, Front. Mol. Biosci. CrossRef
5. Exposure of Keratinocytes to Candida Albicans in the Context of Atopic Milieu Induces Changes in the Surface Glycosylation Pattern of Small Extracellular Vesicles to Enhance Their Propensity to Interact With Inhibitory Siglec Receptors
   Adrian Kobiela et al, 2022, Front. Immunol. CrossRef
6. A Sweet Warning: Mucin-Type O-Glycans in Cancer
   Yuhan Zhang et al, 2022, Cells CrossRef
7. Abnormal Glycosylation in Cancer Cells and Cancer Stem Cells as a Therapeutic Target
   Sabina Quader et al, 2022 CrossRef
8. The Blessed Union of Glycobiology and Immunology: A Marriage That Worked
   Jhenifer Santos dos Reis et al, 2023, Medicines CrossRef
9. Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8+ T Cells
   Lei Tang et al, 2023, CCDT CrossRef
10. Genome-Wide Association Study Identifies Genetic Loci Associated With Fat Cell Number and Overlap With Genetic Risk Loci for Type 2 Diabetes
    Agné Kulyté et al, 2022 CrossRef
11. IgA nephropathy
    Eleni Stamellou et al, 2023, Nat Rev Dis Primers CrossRef
12. Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD‐L1 in Cancer Therapy
    Yazhen Wang et al, 2024, Advanced Science CrossRef
13. Direct evidence of host-mediated glycosylation of NleA and its dependence on interaction with the COPII complex
    Lindsay Burns et al, 2024, Gut Microbes CrossRef
14. Gut permeability among Astronauts during Space missions
    Oluwamayowa S. Akinsuyi et al, 2024, Life Sciences in Space Research CrossRef
15. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma
    Yong Chen et al, 2024, J Cancer Res Clin Oncol CrossRef
16. O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies
    Ellie Karampini et al, 2024 CrossRef
17. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability
    Sarah Stiegeler et al, 2021, Cells CrossRef
18. Genetic variants in C1GALT1 are associated with gastric cancer risk by influencing immune infiltration
    Mengfan Guo et al, 2024, J Biomed Res CrossRef
19. Insights into the role of glycosyltransferase in the targeted treatment of gastric cancer
    Yueling Wang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
20. C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells
    Xiaojuan Bao et al, 2024, Biochemical and Biophysical Research Communications CrossRef
21. Transcriptome analysis of hepatic injury caused by delayed resuscitation following severe burns in rats
    Zhaoxing Liu et al, 2023, J Trauma Acute Care Surg CrossRef
22. C1GALT1 high expression enhances the progression of glioblastoma through the EGFR-AKT/ERK cascade
    Yanting Su et al, 2024, Cellular Signalling CrossRef
23. C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter‐mediated doxorubicin resistance
    Chun‐Wei Liu et al, 2025, The Journal of Pathology CrossRef